Tickwind
TodayOpportunitiesMarketsAI Chat
EN
Log inSign up
Tickwind

Read every tick. See where the market's blowing.

  • X
  • TelegramChinese
  • Newsletter

Product

  • Markets
  • Theme Zones
  • All stocks
  • Compare
  • Hot stocks
  • Opportunities
  • News
  • Discussion
  • Watchlist
  • What's new

Account

  • Settings
  • Newsletter
  • For writers
  • MCP server
  • Contact
  • Log in
  • Sign up
MarketsTheme ZonesAll stocksCompareHot stocksOpportunitiesNewsDiscussionWatchlistWhat's newSettingsNewsletterFor writersMCP serverContactLog inSign up

© 2026 Tickwind. Not investment advice.

Made for the curious investor.

Home/DERM/Capital expenditures

Journey Medical Corp (DERM) Capital expenditures 2023–2025

Journey Medical Corp (DERM) annual capital expenditure history — cash spent on property, plant and equipment, per SEC filings.

$15.0MFY2025 · since FY2023: $20.0M → $15.0M
232425
Fiscal yearValueYoY
FY2025$15.0M+200.0%
FY2024$5.0M-75.0%
FY2023$20.0M—

Capital expenditures are shown as the positive cash amount spent, as reported on the cash-flow statement.

Source: SEC XBRL filings · For reference only · Not investment advice

More DERM financial trends

DERM RevenueDERM Net incomeDERM Net marginDERM Gross profitDERM Gross marginDERM Operating incomeDERM Operating marginDERM Operating cash flowDERM Free cash flowDERM Return on equityDERM Stock buybacksDERM Dividends paidDERM Total assetsDERM Total liabilitiesDERM Shareholders’ equityDERM overview →